FR2653337B1 - Element a liberation prolongee et procede pour le fabriquer. - Google Patents

Element a liberation prolongee et procede pour le fabriquer.

Info

Publication number
FR2653337B1
FR2653337B1 FR8913818A FR8913818A FR2653337B1 FR 2653337 B1 FR2653337 B1 FR 2653337B1 FR 8913818 A FR8913818 A FR 8913818A FR 8913818 A FR8913818 A FR 8913818A FR 2653337 B1 FR2653337 B1 FR 2653337B1
Authority
FR
France
Prior art keywords
manufacturing
same
sustained release
release element
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8913818A
Other languages
English (en)
Other versions
FR2653337A1 (fr
Inventor
Aguadisch Louis
Etienne Alain
Grisoni Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Belgium SPRL
Dow Corning France SAS
Original Assignee
Dow Corning SA
Dow Corning France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning SA, Dow Corning France SAS filed Critical Dow Corning SA
Priority to FR8913818A priority Critical patent/FR2653337B1/fr
Priority to ES90311278T priority patent/ES2044451T3/es
Priority to EP90311278A priority patent/EP0425154B1/fr
Priority to DE90311278T priority patent/DE69003347T2/de
Priority to DK90311278.7T priority patent/DK0425154T3/da
Priority to BR909005223A priority patent/BR9005223A/pt
Priority to CA002027865A priority patent/CA2027865A1/fr
Priority to HU906525A priority patent/HUT69395A/hu
Priority to IE377790A priority patent/IE66826B1/en
Priority to AU64863/90A priority patent/AU639947B2/en
Priority to KR1019900016857A priority patent/KR910007518A/ko
Priority to FI905195A priority patent/FI905195A0/fi
Priority to JP2285678A priority patent/JPH03167116A/ja
Publication of FR2653337A1 publication Critical patent/FR2653337A1/fr
Application granted granted Critical
Publication of FR2653337B1 publication Critical patent/FR2653337B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8913818A 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer. Expired - Lifetime FR2653337B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR8913818A FR2653337B1 (fr) 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer.
EP90311278A EP0425154B1 (fr) 1989-10-23 1990-10-16 Eléments à libération prolongée
DE90311278T DE69003347T2 (de) 1989-10-23 1990-10-16 Elemente mit protrahierter Wirkstoffabgabe.
DK90311278.7T DK0425154T3 (da) 1989-10-23 1990-10-16 Genstande med vedvarende afgivelse af aktivt stof
ES90311278T ES2044451T3 (es) 1989-10-23 1990-10-16 Elementos de liberacion retardada.
CA002027865A CA2027865A1 (fr) 1989-10-23 1990-10-17 Elements a effet prolonge
BR909005223A BR9005223A (pt) 1989-10-23 1990-10-17 Elemento desprendivel permanente e processo para sua fabricacao
HU906525A HUT69395A (en) 1989-10-23 1990-10-20 Process for production of preparation with sustained release
IE377790A IE66826B1 (en) 1989-10-23 1990-10-22 Sustained release elements
AU64863/90A AU639947B2 (en) 1989-10-23 1990-10-22 Sustained release elements
KR1019900016857A KR910007518A (ko) 1989-10-23 1990-10-22 서방성 제제
FI905195A FI905195A0 (fi) 1989-10-23 1990-10-22 Laongvarigt frigoerande element.
JP2285678A JPH03167116A (ja) 1989-10-23 1990-10-23 徐放性エレメントおよびその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913818A FR2653337B1 (fr) 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer.

Publications (2)

Publication Number Publication Date
FR2653337A1 FR2653337A1 (fr) 1991-04-26
FR2653337B1 true FR2653337B1 (fr) 1992-02-07

Family

ID=9386646

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8913818A Expired - Lifetime FR2653337B1 (fr) 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer.

Country Status (13)

Country Link
EP (1) EP0425154B1 (fr)
JP (1) JPH03167116A (fr)
KR (1) KR910007518A (fr)
AU (1) AU639947B2 (fr)
BR (1) BR9005223A (fr)
CA (1) CA2027865A1 (fr)
DE (1) DE69003347T2 (fr)
DK (1) DK0425154T3 (fr)
ES (1) ES2044451T3 (fr)
FI (1) FI905195A0 (fr)
FR (1) FR2653337B1 (fr)
HU (1) HUT69395A (fr)
IE (1) IE66826B1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
FR2677253A1 (fr) * 1991-06-07 1992-12-11 Union Metropolitaine Pharmaceu Composition therapeutique utile vis-a-vis des maladies inflammatoires du systeme gastro-intestinal.
WO1993007114A1 (fr) * 1991-09-24 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Derives a substitution oxygene de produits d'addition de nucleophile-oxyde nitrique utilises comme promedicaments donneurs d'oxyde nitrique
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
FR2752380B1 (fr) * 1996-08-14 1998-10-30 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
WO2002043694A2 (fr) 2000-11-28 2002-06-06 Fmc Corporation Composition d'enrobage comestible en alginate de propylene glycol
KR100477364B1 (ko) * 2002-07-03 2005-03-22 주식회사 메디켐스 신규한 헬리코박터 파이로리 균 진단용 13c-요소 캅셀 제제
AR040682A1 (es) 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
EA201001086A1 (ru) 2004-08-13 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
PL1781260T5 (pl) 2004-08-13 2014-09-30 Boehringer Ingelheim Int Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól, sposób wytwarzania tego preparatu i jego zastosowanie
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
WO2007086078A2 (fr) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Compositions pharmaceutiques atypiques et processus de preparation correspondant
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
CN102892440B (zh) 2010-04-14 2014-10-29 莫恩里克保健股份公司 抗微生物凝胶
EP2568968B1 (fr) 2010-05-10 2017-07-12 Euro-Celtique S.A. Fabrication de granules libres de principes actifs et comprimés les contenant
TWI590835B (zh) 2010-05-10 2017-07-11 歐 賽提克股份有限公司 含有氫嗎啡酮(hydromorphone)和納洛酮(naloxone)之藥學組成物
CA2798885C (fr) 2010-05-10 2014-11-18 Euro-Celtique S.A. Combinaison de granules charges de principe actif et de principes actifs supplementaires
GB201020895D0 (en) 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
EA030310B1 (ru) 2013-11-13 2018-07-31 Эро-Селтик С.А. Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника
KR101599126B1 (ko) 2014-04-01 2016-03-14 주식회사 명성 스크루식 뚜껑 성형장치
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals
WO2023148315A1 (fr) * 2022-02-03 2023-08-10 Basf Se Tartrate de potassium et de sodium en tant qu'adjuvant de granulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3991750A (en) * 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
CA1331338C (fr) * 1987-02-03 1994-08-09 Dow Corning Corporation Compositions aqueuses formant une pellicule, utilisees pour reguler la liberation d'agents actifs, et procede pour leur fabrication
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device

Also Published As

Publication number Publication date
FI905195A0 (fi) 1990-10-22
AU6486390A (en) 1991-04-26
IE66826B1 (en) 1996-02-07
EP0425154A1 (fr) 1991-05-02
DE69003347D1 (de) 1993-10-21
FR2653337A1 (fr) 1991-04-26
BR9005223A (pt) 1991-09-17
IE903777A1 (en) 1991-04-24
KR910007518A (ko) 1991-05-30
ES2044451T3 (es) 1994-01-01
DE69003347T2 (de) 1994-02-17
EP0425154B1 (fr) 1993-09-15
CA2027865A1 (fr) 1991-04-24
DK0425154T3 (da) 1993-11-01
HUT69395A (en) 1995-09-28
AU639947B2 (en) 1993-08-12
HU906525D0 (en) 1991-04-29
JPH03167116A (ja) 1991-07-19

Similar Documents

Publication Publication Date Title
FR2653337B1 (fr) Element a liberation prolongee et procede pour le fabriquer.
FR2658394B1 (fr) Cigarette, et procede pour la fabriquer.
NO962486D0 (no) Automatisk dör
NO910844L (no) Apparat for tilvirkning av id-kort.
FR2662819B1 (fr) Materiau microprismatique reflechissant et son procede de fabrication.
TR27174A (tr) Vinilasetatin üretilmesine mahsus usul.
FR2655292B1 (fr) Materiau stratifie pour elements de glissement, et procede de fabrication dudit materiau.
NO903758L (no) Glutarimider.
DE69012013D1 (de) Mehrfachlochfiltergerät.
FI901875A0 (fi) Fuktande vehikel foer lokal anvaendning av a-vitaminsyra.
DE69004192D1 (de) Induktive Vorrichtung.
FI916057A0 (fi) Pressanordning med upphettat foerlaengt nyp.
NO902213L (no) Tverrbindbare interpolymere.
FR2683054B1 (fr) Modulateur electrooptique integre et procede de fabrication de ce modulateur.
NO911724D0 (no) Anordning for fremstilling av foeringer.
NO894583D0 (no) Fremgangsmaate for fremstilling av celleplast.
FI902336A0 (fi) Anordning foer framstaellning av en fristaoende kiselkristall.
FR2664745B1 (fr) Convertisseur thermoelectrique et procede pour sa fabrication.
DK0509342T3 (da) Fremgangsmåde til fremstilling af kileformede strukturer
FI901413A0 (fi) Anordning foer framstaellning av kiselenkristaller.
KR900700557A (ko) 열-전달 유체 및 이의 제조방법
TR25474A (tr) PROPILEN-ETILEN-COPOLIMERISATLARIN üRETIMINE ILIS- KIN YÖNTEM
FR2667884B3 (fr) Element de construction et procede pour sa fabrication.
FR2653360B1 (fr) Granulat pour travaux publics et procede pour le fabriquer.
IT8920558A0 (it) Dispositivo a laminatorio.

Legal Events

Date Code Title Description
ST Notification of lapse